FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Michael Kass

Research Profile

Disorders

Physiology

Concepts & Ideas

Chemicals & Drugs

Anatomy

Procedures

Activities & Behaviors

Photography

Co-author Network

Publications

TOP 3
Linda M Zangwill; James Brandt; George A Cioffi; Anne L Coleman; Keri Dirkes; Mae O Gordon; Feng He; Sonia Jain; Michael A Kass; Jeffrey M Liebmann; Felipe A Medeiros; Jody R Piltz-Seymour; Gary Trick; Robert N Weinreb
The rate of structural change: the confocal scanning laser ophthalmoscopy ancillary study to the ocular hypertension treatment study.
Steven L Mansberger; Brad Wilson; Anjali Bhorade; James Brandt; Mae O Gordon; Henry D Jampel; Michael A Kass
Reduction in intraocular pressure after cataract extraction: the Ocular Hypertension Treatment Study.
James Brandt; Feng Gao; Mae O Gordon; Michael A Kass; J. Philip Miller; Julia A Beiser
Adjusting intraocular pressure for central corneal thickness does not improve prediction models for primary open-angle glaucoma.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Michael Kass (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Linda M Zangwill; James Brandt; George A Cioffi; Anne L Coleman; Keri Dirkes; Mae O Gordon; Feng He; Sonia Jain; Michael A Kass; Jeffrey M Liebmann; Felipe A Medeiros; Jody R Piltz-Seymour; Gary Trick; Robert N Weinreb
The rate of structural change: the confocal scanning laser ophthalmoscopy ancillary study to the ocular hypertension treatment study.
American journal of ophthalmology 2013;155(6):971-82.
2012: Steven L Mansberger; Brad Wilson; Anjali Bhorade; James Brandt; Mae O Gordon; Henry D Jampel; Michael A Kass
Reduction in intraocular pressure after cataract extraction: the Ocular Hypertension Treatment Study.
Ophthalmology 2012;119(9):1826-31.
2012: James Brandt; Feng Gao; Mae O Gordon; Michael A Kass; J. Philip Miller; Julia A Beiser
Adjusting intraocular pressure for central corneal thickness does not improve prediction models for primary open-angle glaucoma.
Ophthalmology 2012;119(3):437-42.
2012: Feng Gao; Julia A Beiser; Michael A Kass; Stefano Miglior; J Philip Miller; Valter Torri; Mae O Gordon
The effect of changes in intraocular pressure on the risk of primary open-angle glaucoma in patients with ocular hypertension: an application of latent class analysis.
BMC medical research methodology 2012;12():151.
2010: Paul H Artes; Balwantray C Chauhan; John L Keltner; Kimberly E Cello; Chris A Johnson; Douglas R Anderson; Mae O Gordon; Michael A Kass
Longitudinal and cross-sectional analyses of visual field progression in participants of the Ocular Hypertension Treatment Study.
Archives of ophthalmology 2010;128(12):1528-32.
2010: Anjali M Bhorade; Bradley S Wilson; Mae O Gordon; Paul F Palmberg; Robert N Weinreb; Eydie Miller; Robert Chang; Michael A Kass
The utility of the monocular trial: data from the ocular hypertension treatment study.
Ophthalmology 2010;117(11):2047-54.
2010: Robert N Weinreb; Linda M Zangwill; Sonia Jain; Lida M Becerra; Keri Dirkes; Jody R Piltz-Seymour; George A Cioffi; Gary L Trick; Anne L Coleman; James Brandt; Jefferey M Liebmann; Mae O Gordon; Michael A Kass
Predicting the onset of glaucoma: the confocal scanning laser ophthalmoscopy ancillary study to theOcular Hypertension Treatment Study.
Ophthalmology 2010;117(9):1674-83.
2010: Steven M Kymes; Michael R Plotzke; Michael A Kass; Michael Boland; Mae O Gordon
Effect of patient's life expectancy on the cost-effectiveness of treatment for ocular hypertension.
Archives of ophthalmology 2010;128(5):613-8.
2010: Michael A Kass; Mae O Gordon; Feng Gao; Dale K Heuer; Eve Juliet Higginbotham; Chris A Johnson; John L Keltner; J. Philip Miller; Richard K Parrish; M Roy Wilson
Delaying treatment of ocular hypertension: the ocular hypertension treatment study.
Archives of ophthalmology 2010;128(3):276-87.
2010: Edward M Barnett; Aldo Fantin; Bradley S Wilson; Michael A Kass; Mae O Gordon
The incidence of retinal vein occlusion in the ocular hypertension treatment study.
Ophthalmology 2010;117(3):484-8.
2008: James Brandt; Mae O Gordon; Julia A Beiser; Shan C Lin; Monica Y Alexander; Michael A Kass
Changes in central corneal thickness over time: the ocular hypertension treatment study.
Ophthalmology 2008;115(9):1550-6, 1556.e1.
2008: Mae O Gordon; Julia A Beiser; Michael A Kass
Is a history of diabetes mellitus protective against developing primary open-angle glaucoma?
Archives of ophthalmology 2008;126(2):280-1.
2007: John L Keltner; Chris A Johnson; Kimberly E Cello; Shannan E Bandermann; Juanjuan Fan; Richard A Levine; Michael A Kass; Mae O Gordon
Visual field quality control in the Ocular Hypertension Treatment Study (OHTS).
Journal of glaucoma 2007;16(8):665-9.
2007: Steven L Mansberger; Bret A Hughes; Mae O Gordon; Steven D Spaner; Julia A Beiser; George A Cioffi; Michael A Kass
Comparison of initial intraocular pressure response with topical beta-adrenergic antagonists and prostaglandin analogues in African American and white individuals in the Ocular Hypertension Treatment Study.
Archives of ophthalmology 2007;125(4):454-9.
2007: Mae O Gordon; Valter Torri; Stefano Miglior; Julia A Beiser; Irene Floriani; J. Philip Miller; Feng Gao; Ingrid Adamsons; Davide Poli; Ralph B D'Agostino; Michael A Kass
Validated prediction model for the development of primary open-angle glaucoma in individuals with ocular hypertension.
Ophthalmology 2007;114(1):10-9.
2006: Donald L Budenz; Douglas R Anderson; William J Feuer; Julia A Beiser; Joyce C. Schiffman; Richard K Parrish; Jody R Piltz-Seymour; Mae O Gordon; Michael A Kass
Detection and prognostic significance of optic disc hemorrhages during the Ocular Hypertension Treatment Study.
Ophthalmology 2006;113(12):2137-43.
2006: David C Herman; Mae O Gordon; Julia A Beiser; Leo T Chylack; Kathleen A Lamping; Oliver D Schein; Joern B Soltau; Michael A Kass
Topical ocular hypotensive medication and lens opacification: evidence from the ocular hypertension treatment study.
American journal of ophthalmology 2006;142(5):800-10.
2006: John L Keltner; Chris A Johnson; Douglas R Anderson; Richard A Levine; Juanjuan Fan; Kimberly E Cello; Harry A Quigley; Donald L Budenz; Richard K Parrish; Michael A Kass; Mae O Gordon
The association between glaucomatous visual fields and optic nerve head features in the Ocular Hypertension Treatment Study.
Ophthalmology 2006;113(9):1603-12.
2006: Richard A Levine; Shaban Demirel; Juanjuan Fan; John L Keltner; Chris A Johnson; Michael A Kass
Asymmetries and visual field summaries as predictors of glaucoma in the ocular hypertension treatment study.
Investigative ophthalmology & visual science 2006;47(9):3896-903.
2006: Steven M Kymes; Michael A Kass; Douglas R Anderson; J. Philip Miller; Mae O Gordon
Management of ocular hypertension: a cost-effectiveness approach from the Ocular Hypertension Treatment Study.
American journal of ophthalmology 2006;141(6):997-1008.
2005: Richard K Parrish; Joyce C. Schiffman; William J Feuer; Douglas R Anderson; Donald L Budenz; Maria-Cristina Wells-Albornoz; Ruth Vandenbroucke; Michael A Kass; Mae O Gordon
Test-retest reproducibility of optic disk deterioration detected from stereophotographs by masked graders.
American journal of ophthalmology 2005;140(4):762-4.
2005: John L Keltner; Chris A Johnson; Richard A Levine; Juanjuan Fan; Kimberly E Cello; Michael A Kass; Mae O Gordon
Normal visual field test results following glaucomatous visual field end points in the Ocular Hypertension Treatment Study.
Archives of ophthalmology 2005;123(9):1201-6.
2005: Linda M Zangwill; Robert N Weinreb; Julia A Beiser; Charles C Berry; George A Cioffi; Anne L Coleman; Gary Trick; Jeffrey M Liebmann; James Brandt; Jody R Piltz-Seymour; Keri A Dirkes; Suzanne Vega; Michael A Kass; Mae O Gordon
Baseline topographic optic disc measurements are associated with the development of primary open-angle glaucoma: the Confocal Scanning Laser Ophthalmoscopy Ancillary Study to the Ocular Hypertension Treatment Study.
Archives of ophthalmology 2005;123(9):1188-97.
2005: Michael A Kass; Mae O Gordon; Steven M Kymes
Incorporating the results of the Ocular Hypertension Treatment Study into clinical practice.
Archives of ophthalmology 2005;123(7):1021-2.
2004: James Brandt; Julia A Beiser; Mae O Gordon; Michael A Kass
Central corneal thickness and measured IOP response to topical ocular hypotensive medication in the Ocular Hypertension Treatment Study.
American journal of ophthalmology 2004;138(5):717-22.
2004: Anne L Coleman; Mae O Gordon; Julia A Beiser; Michael A Kass
Baseline risk factors for the development of primary open-angle glaucoma in the Ocular Hypertension Treatment Study.
American journal of ophthalmology 2004;138(4):684-5.
2004: Eve Juliet Higginbotham; Mae O Gordon; Julia A Beiser; Michael V Drake; G Richard Bennett; M R Wilson; Michael A Kass
The Ocular Hypertension Treatment Study: topical medication delays or prevents primary open-angle glaucoma in African American individuals.
Archives of ophthalmology 2004;122(6):813-20.
2004: Linda M Zangwill; Robert N Weinreb; Charles C Berry; Amanda R Smith; Keri A Dirkes; Jeffrey M Liebmann; James Brandt; Gary Trick; George A Cioffi; Anne L Coleman; Jody R Piltz-Seymour; Mae O Gordon; Michael A Kass
The confocal scanning laser ophthalmoscopy ancillary study to the ocular hypertension treatment study: study design and baseline factors.
American journal of ophthalmology 2004;137(2):219-27.
2004: Linda M Zangwill; Robert N Weinreb; Charles C Berry; Amanda R Smith; Keri A Dirkes; Anne L Coleman; Jody R Piltz-Seymour; Jeffrey M Liebmann; George A Cioffi; Gary Trick; James Brandt; Mae O Gordon; Michael A Kass
Racial differences in optic disc topography: baseline results from the confocal scanning laser ophthalmoscopy ancillary study to the ocular hypertension treatment study.
Archives of ophthalmology 2004;122(1):22-8.
2003: John L Keltner; Chris A Johnson; Kimberly E Cello; Mary A Edwards; Shannan E Bandermann; Michael A Kass; Mae O Gordon
Classification of visual field abnormalities in the ocular hypertension treatment study.
Archives of ophthalmology 2003;121(5):643-50.
2002: Mae O Gordon; Julia A Beiser; James Brandt; Dale K Heuer; Eve Juliet Higginbotham; Chris A Johnson; John L Keltner; J. Philip Miller; Richard K Parrish; M R Wilson; Michael A Kass
The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma.
Archives of ophthalmology 2002;120(6):714-20; discussion 829-30.
2002: Michael A Kass; Dale K Heuer; Eve Juliet Higginbotham; Chris A Johnson; John L Keltner; J. Philip Miller; Richard K Parrish; M R Wilson; Mae O Gordon
The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma.
Archives of ophthalmology 2002;120(6):701-13; discussion 829-30.
2002: Chris A Johnson; John L Keltner; Kimberly E Cello; Mary Edwards; Michael A Kass; Mae O Gordon; Donald L Budenz; Douglas E Gaasterland; Elliot Werner
Baseline visual field characteristics in the ocular hypertension treatment study.
Ophthalmology 2002;109(3):432-7.
2002: William J Feuer; Richard K Parrish; Joyce C. Schiffman; Douglas R Anderson; Donald L Budenz; Maria-Cristina Wells; Ditte J Hess; Michael A Kass; Mae O Gordon
The Ocular Hypertension Treatment Study: reproducibility of cup/disk ratio measurements over time at an optic disc reading center.
American journal of ophthalmology 2002;133(1):19-28.
2001: James Brandt; Julia A Beiser; Michael A Kass; Mae O Gordon
Central corneal thickness in the Ocular Hypertension Treatment Study (OHTS).
Ophthalmology 2001;108(10):1779-88.
2001: Gülgün Tezel; KD Siegmund; Kathryn M Trinkaus; Martin B Wax; Michael A Kass; AE Kolker
Clinical factors associated with progression of glaucomatous optic disc damage in treated patients.
Archives of ophthalmology 2001;119(6):813-8.
2000: Michael A Kass; Mae O Gordon
Intraocular pressure and visual field progression in open-angle glaucoma.
American journal of ophthalmology 2000;130(4):490-1.
2000: JR Piltz; R Gross; Dong H Shin; Julia A Beiser; David A Dorr; Michael A Kass; Mae O Gordon
Contralateral effect of topical beta-adrenergic antagonists in initial one-eyed trials in the ocular hypertension treatment study.
American journal of ophthalmology 2000;130(4):441-53.
2000: John L Keltner; Chris A Johnson; J M Quigg; Kimberly E Cello; Michael A Kass; Mae O Gordon
Confirmation of visual field abnormalities in the Ocular Hypertension Treatment Study. Ocular Hypertension Treatment Study Group.
Archives of ophthalmology 2000;118(9):1187-94.
2000: Gülgün Tezel; David A Dorr; AE Kolker; Martin B Wax; Michael A Kass
Concordance of parapapillary chorioretinal atrophy in ocular hypertension with visual field defects that accompany glaucoma development.
Ophthalmology 2000;107(6):1194-9.
1999: Mae O Gordon; Michael A Kass
The Ocular Hypertension Treatment Study: design and baseline description of the participants.
Archives of ophthalmology 1999;117(5):573-83.
1998: Gülgün Tezel; AE Kolker; Michael A Kass; Martin B Wax
Late removal of releasable sutures after trabeculectomy or combined trabeculectomy with cataract extraction supplemented with antifibrotics.
Journal of glaucoma 1998;7(2):75-81.
1997: Gülgün Tezel; AE Kolker; Martin B Wax; Michael A Kass; M Gordon; KD Siegmund
Parapapillary chorioretinal atrophy in patients with ocular hypertension. II. An evaluation of progressive changes.
Archives of ophthalmology 1997;115(12):1509-14.
1997: Gülgün Tezel; AE Kolker; Michael A Kass; Martin B Wax; M Gordon; KD Siegmund
Parapapillary chorioretinal atrophy in patients with ocular hypertension. I. An evaluation as a predictive factor for the development of glaucomatous damage.
Archives of ophthalmology 1997;115(12):1503-8.
1997: Gülgün Tezel; AE Kolker; Michael A Kass; Martin B Wax
Comparative results of combined procedures for glaucoma and cataract: II. Limbus-based versus fornix-based conjunctival flaps.
Ophthalmic surgery and lasers 1997;28(7):551-7.
1997: Gülgün Tezel; AE Kolker; Michael A Kass; Martin B Wax
Comparative results of combined procedures for glaucoma and cataract: I. Extracapsular cataract extraction versus phacoemulsification and foldable versus rigid intraocular lenses.
Ophthalmic surgery and lasers 1997;28(7):539-50.
1997: J C Burchfield; Michael A Kass; Martin B Wax
Primary valve malfunction of the Krupin eye valve with disk.
Journal of glaucoma 1997;6(3):152-6.
1997: Gülgün Tezel; Michael A Kass; AE Kolker; B Becker; Martin B Wax
Plasma and aqueous humor endothelin levels in primary open-angle glaucoma.
Journal of glaucoma 1997;6(2):83-9.
1996: Gülgün Tezel; Michael A Kass; AE Kolker; Martin B Wax
Comparative optic disc analysis in normal pressure glaucoma, primary open-angle glaucoma, and ocular hypertension.
Ophthalmology 1996;103(12):2105-13.
1996: Michael A Kass
Standardizing the measurement of intraocular pressure for clinical research. Guidelines from the Eye Care Technology Forum.
Ophthalmology 1996;103(1):183-5.
1995: C Lin; Gregg T Lueder; Michael A Kass
Ocular abnormalities in a patient with Rothmund-Thomson syndrome.
Journal of pediatric ophthalmology and strabismus 1995;32(2):132-4.
1994: E N Fang; Michael A Kass
Increased intraocular pressure after cataract surgery.
Seminars in ophthalmology 1994;9(4):235-42.
1994: Michael A Kass
The ocular hypertension treatment study.
Journal of glaucoma 1994;3(2):97-100.
1994: Robert Ritch; Michael A Kass; Jacob T Wilensky; J M Ruderman
Chronic uveitis and glaucoma.
Journal of glaucoma 1994;3(1):84-91.
1994: AE Kolker; Michael A Kass; J L Rait
Trabeculectomy with releasable sutures.
Archives of ophthalmology 1994;112(1):62-6.
1993: Jacob T Wilensky; P L Kaufman; D Frohlichstein; D K Gieser; Michael A Kass; R Ritch; Robert J Anderson
Follow-up of angle-closure glaucoma suspects.
American journal of ophthalmology 1993;115(3):338-46.
1993: Mae O Gordon; Michael A Kass
Ocular hypertension treatment study: design issues.
Journal of glaucoma 1993;2 Suppl A():24-5.
1993: Michael A Kass; Mae O Gordon; M R Hoff; J M Parkinson; AE Kolker; WM Hart; B Becker
Topical timolol administration reduces the incidence of glaucomatous damage in ocular hypertensive individuals. A randomized, double-masked, long-term clinical trial (1).
Journal of glaucoma 1993;2 Suppl A():1-2.
1993: AE Kolker; Michael A Kass; J L Rait
Trabeculectomy with releasable sutures.
Transactions of the American Ophthalmological Society 1993;91():131-41; discussion 141-5.
1992: Mark A Latina; S Melamed; W F March; Michael A Kass; AE Kolker
Gonioscopic ab interno laser sclerostomy. A pilot study in glaucoma patients.
Ophthalmology 1992;99(11):1736-44.
1990: R Nesher; Michael A Kass; L A Gans
Corneal endothelial changes in ocular hypertensive individuals after long-term unilateral treatment with timolol.
American journal of ophthalmology 1990;110(3):309-10.
1990: R Nesher; G L Trick; Michael A Kass; M O Gordon
Steady-state pattern electroretinogram following long term unilateral administration of timolol to ocular hypertensive subjects.
Documenta ophthalmologica. Advances in ophthalmology 1990;75(2):101-9.
1990: J W Kalenak; J M Parkinson; Michael A Kass; AE Kolker
Transscleral neodymium: YAG laser cyclocoagulation for uncontrolled glaucoma.
Ophthalmic surgery 1990;21(5):346-51.
1989: Michael A Kass; M O Gordon; M R Hoff; J M Parkinson; AE Kolker; WM Hart; B Becker
Topical timolol administration reduces the incidence of glaucomatous damage in ocular hypertensive individuals. A randomized, double-masked, long-term clinical trial.
Archives of ophthalmology 1989;107(11):1590-8.
1989: Michael A Kass
Topical carbonic anhydrase inhibitors.
American journal of ophthalmology 1989;107(3):280-2.
1988: J M Lewis; T Priddy; J Judd; M O Gordon; Michael A Kass; AE Kolker; B Becker
Intraocular pressure response to topical dexamethasone as a predictor for the development of primary open-angle glaucoma.
American journal of ophthalmology 1988;106(5):607-12.
1988: S M Shields; J L Stevens; Michael A Kass; M E Smith
Histopathologic findings after Nd:YAG transscleral cyclophotocoagulation.
American journal of ophthalmology 1988;106(1):100-1.
1987: D Messner; L I Siegel; Michael A Kass; AE Kolker; M Gordon
Repeat argon laser trabeculoplasty.
American journal of ophthalmology 1987;103(1):113-5.
1985: Theodore Krupin; R A Stone; B H Cohen; AE Kolker; Michael A Kass
Acute intraocular pressure response to argon laser iridotomy.
Ophthalmology 1985;92(7):922-6.
1984: Theodore Krupin; AE Kolker; Michael A Kass; B Becker
Intraocular pressure the day of argon laser trabeculoplasty in primary open-angle glaucoma.
Ophthalmology 1984;91(4):361-5.
1982: M S Korey; E Hodapp; Michael A Kass; I Goldberg; M Gordon; B Becker
Timolol and epinephrine: long-term evaluation of concurrent administration.
Archives of ophthalmology 1982;100(5):742-5.
1982: Michael A Kass; D K Gieser; E Hodapp; B Becker; C E Bell
Corticosteroid-induced iridocyclitis in a family.
American journal of ophthalmology 1982;93(3):368-9.
1981: D K Gieser; M Tanenbaum; M E Smith; Michael A Kass; N E Christy; H Friesen; O Otterlei; B Becker
Amorphous coating in open-angle glaucoma.
American journal of ophthalmology 1981;92(1):130-3.
1981: E Hodapp; AE Kolker; Michael A Kass; I Goldberg; B Becker; M Gordon
The effect of topical clonidine on intraocular pressure.
Archives of ophthalmology 1981;99(7):1208-11.
1981: Michael A Kass; AE Kolker; M Gordon; I Goldberg; D K Gieser; Theodore Krupin; B Becker
Acetazolamide and urolithiasis.
Ophthalmology 1981;88(3):261-5.
1980: Michael A Kass; WM Hart; M Gordon; J. Philip Miller
Risk factors favoring the development of glaucomatous visual field loss in ocular hypertension.
Survey of ophthalmology 1980;25(3):155-62.